Effects of GM1 ganglioside in cerebrovascular diseases: a double-blind trial in 40 cases.

1985 
A randomized, double-blind trial on the effects of GM1 ganglioside in cerebrovascular diseases was done on 40 patients; the treatment (40 mg/day i.m. injection) began after the acute phase
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    41
    Citations
    NaN
    KQI
    []